Primary Category:
Treatment Protocols
Disease Category:
Breast, Breast Metastatic
Status:
Open
A Phase II Trial of Sacituzumab Govitecan (IMMU-132) (NSC #820016) for Patients with HER2-Negative Breast Cancer and Brain Metastases
NCT#04647916
Primary Category:
Treatment Protocols
Disease Category:
Breast, Breast Metastatic
Status:
Open
A Phase II Trial of Sacituzumab Govitecan (IMMU-132) (NSC #820016) for Patients with HER2-Negative Breast Cancer and Brain Metastases
NCT#04647916